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Original Investigation | Cardiology

Association of Alcohol Consumption After Development
of Heart Failure With Survival Among Older Adults
in the Cardiovascular Health Study
Justin S. Sadhu, MD, MPHS; Eric Novak, MS; Kenneth J. Mukamal, MD, MPH; Jorge R. Kizer, MD, MSc; Bruce M. Psaty, MD, PhD; Phyllis K. Stein, PhD; David L. Brown, MD

Abstract

Key Points

IMPORTANCE More than 1 million older adults develop heart failure annually. The association of
alcohol consumption with survival among these individuals after diagnosis is unknown.

Question What is the association of
alcohol consumption after the diagnosis
of heart failure with survival among

OBJECTIVE To determine whether alcohol use is associated with increased survival among older

older adults?
Findings In this cohort study of 393

adults with incident heart failure.

older adults with incident heart failure,

DESIGN, SETTING, AND PARTICIPANTS This prospective cohort study included 5888 community-

consumption of 7 or fewer alcoholic

dwelling adults aged 65 years or older who were recruited to participate in the Cardiovascular Health

drinks per week was significantly

Study between June 12, 1989, and June 1993, from 4 US sites. Of the total participants, 393

associated with increased survival

individuals had a new diagnosis of heart failure within the first 9 years of follow-up through June

compared with abstinence from alcohol,

2013. The study analysis was performed between January 19, 2016, and September 22, 2016.

after controlling for other factors.
Meaning Limited alcohol consumption

EXPOSURES Alcohol consumption was divided into 4 categories: abstainers (never drinkers),
former drinkers, 7 or fewer alcoholic drinks per week, and more than 7 drinks per week.

among older adults with incident heart
failure may be associated with increased
survival.

PRIMARY OUTCOMES AND MEASURES Participant survival after the diagnosis of incident
heart failure.
RESULTS Among the 393 adults diagnosed with incident heart failure, 213 (54.2%) were female, 339

Author affiliations and article information are
listed at the end of this article.

(86.3%) were white, and the mean (SD) age was 78.7 (6.0) years. Alcohol consumption after
diagnosis was reported in 129 (32.8%) of the participants. Across alcohol consumption categories of
long-term abstainers, former drinkers, consumers of 1-7 drinks weekly and consumers of more than
7 drinks weekly, the percentage of men (32.1%, 49.0%, 58.0%, and 82.4%, respectively; P < .001 for
trend), white individuals (78.0%, 92.7%, 92.0%, and 94.1%, respectively, P <. 001 for trend), and
high-income participants (22.0%, 43.8%, 47.3%, and 64.7%, respectively; P < .001 for trend)
increased with increasing alcohol consumption. Across the 4 categories, participants who consumed
more alcohol had more years of education (mean, 12 years [interquartile range (IQR), 8.0-10.0 years],
12 years [IQR, 11.0-14.0 years], 13 years [IQR, 12.0-15.0 years], and 13 years [IQR, 12.0-14.0 years];
P < .001 for trend). Diabetes was less common across the alcohol consumption categories (32.1%,
26.0%, 22.3%, and 5.9%, respectively; P = .01 for trend). Across alcohol consumption categories,
there were fewer never smokers (58.3%, 44.8%, 35.7%, and 29.4%, respectively; P < .001 for trend)
and more former smokers (34.5%, 38.5%, 50.0%, and 52.9%, respectively; P = .006 for trend).
After controlling for other factors, consumption of 7 or fewer alcoholic drinks per week was
associated with additional mean survival of 383 days (95% CI, 17-748 days; P = .04) compared with
abstinence from alcohol. Although the robustness was limited by the small number of individuals
who consumed more than 7 drinks per week, a significant inverted U-shaped association between
(continued)
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Abstract (continued)

alcohol consumption and survival was observed. Multivariable model estimates of mean time from
heart failure diagnosis to death were 2640 days (95% CI, 1967-3313 days) for never drinkers, 3046
days (95% CI, 2372-3719 days) for consumers of 1 to 7 drinks per week, and 2806 (95% CI, 1879-3734
days) for consumers of more than 7 drinks per week (P = .02). Consumption of 10 drinks per week
was associated with the longest survival, a mean of 3381 days (95% CI, 2806-3956 days) after heart
failure diagnosis.
CONCLUSIONS AND RELEVANCE These findings suggest that limited alcohol consumption among
older adults with incident heart failure is associated with survival benefit compared with long-term
abstinence. These findings suggest that older adults who develop heart failure may not need to
abstain from moderate levels of alcohol consumption.
JAMA Network Open. 2018;1(8):e186383.
Corrected on February 1, 2019. doi:10.1001/jamanetworkopen.2018.6383

Introduction
The association between alcohol consumption and heart failure (HF) is complex. Although excessive
alcohol consumption may result in HF due to an alcoholic cardiomyopathy,1,2 moderate alcohol
consumption has been associated with a reduction in the risk of incident HF.3-6 However, a more
recent analysis suggests that alcohol consumption of more than approximately 7 drinks per week is
associated with an increased hazard of HF, with a neutral association observed with less alcohol
consumption.7 In contrast to the conflicting data regarding the association between previous alcohol
consumption and development of HF, to our knowledge, there are no data regarding the safety of
alcohol consumption in patients following a new diagnosis of HF. Previous studies examining alcohol
use in adults with HF have yielded mixed results, but they were limited to individuals with prevalent
disease.8-11 Thus, the possibility of a survivor bias influencing these results cannot be excluded. With
more than 1 million new cases of HF diagnosed annually in the United States among individuals 55
years or older,12 data regarding the association of alcohol consumption in this population is lacking.
We sought to examine the association between alcohol consumption and survival following the
diagnosis of HF in a cohort of older adults in a community setting.

Methods
This investigation conforms to the principles outlined in the Declaration of Helsinki.13 Because
Cardiovascular Health Study data were deidentified, the Washington University Office of Human
Research Protection, St Louis, Missouri, granted an exemption from institutional review board
review. The study followed the Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) reporting guideline.14 The study analysis was performed between January
19, 2016, and September 22, 2016.
The Cardiovascular Health Study is a prospective cohort study of 5888 black and white adults
aged 65 years or older in the United States. Detailed descriptions of the Cardiovascular Health Study
have been previously published.15,16 Participants were recruited from 4 US sites: Forsyth County,
North Carolina; Sacramento County, California; Pittsburgh, Pennsylvania; and Washington County,
Maryland. They received baseline clinical examinations from 1989 through 1993, followed by 9 yearly
clinic visits.
Baseline alcohol consumption was determined at the initial visit, and former drinkers were
differentiated from abstainers (never drinkers).5 Alcohol consumption was ascertained in a similar
manner during follow-up years 2 through 5 and years 7 through 9 but was not obtained in follow-up
years 1 and 6 for administrative reasons.5 To allow for assessment of alcohol consumption during the
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first visit after the diagnosis of HF, only patients with incident HF diagnosed during the first 10 years
of the Cardiovascular Health Study were included. An alcoholic beverage was defined as a 12-oz beer,
a 6-oz glass of wine, or a shot (1.5 ounces) of liquor, and alcohol consumption was reported by each
participant as the number of alcoholic beverages consumed per week.
Clinical events were ascertained by telephone calls twice per year, with follow-up available
through June 30, 2013. Diagnoses of HF were adjudicated by the Cardiovascular Health Study Events
Committee and required (1) a diagnosis of HF by a physician and medical treatment for congestive
HF or (2) imaging evidence of cardiomegaly and pulmonary edema by chest radiography or dilated
ventricle and reduced systolic function by echocardiography or contrast ventriculography.
Based on the first available measure of alcohol consumption following a new diagnosis of HF,
study participants were divided into 4 categories: (1) abstainers (never drinkers), (2) former drinkers,
(3) persons consuming 7 or fewer alcoholic drinks per week, and (4) persons consuming more than
7 drinks per week. A cutoff of 7 drinks per week was chosen because this is the recommended
maximum alcohol consumption for this age population.17,18

Statistical Analysis
Cross-sectional associations were assessed using analysis of variance, Fisher exact test, or KruskalWallis tests, as appropriate. Trends among abstainers, participants consuming 7 or fewer drinks per
week, and those consuming more than 7 drinks per week were evaluated by Spearman correlation
coefficient for continuous or ordinal variables, the Mantel-Haenszel χ2 test for linear association for
ordinal variables, and the Cochran-Armitage trend test for dichotomous variables. We excluded
former alcohol drinkers from the analyses of trends because they do not constitute an ordinal
category of alcohol consumption. Former drinkers may have quit drinking in response to changes in
health (sick quitters), and we were interested in examining how continued alcohol consumption after
diagnosis of HF was related to survival compared with long-term abstinence.
We used multiple linear regression to model the association between alcohol consumption as a
categorical variable and subsequent survival (time from diagnosis of HF to death or last follow-up)19
after adjustment for age, sex, race/ethnicity, educational level, income, smoking status, marital
status, hypertension, diabetes, stroke, myocardial infarction, atrial fibrillation, angiotensinconverting enzyme inhibitor use, β-blocker use, systolic blood pressure, diastolic blood pressure,
body mass index, 15-ft walk time, glomerular filtration rate, and the presence of left ventricular
hypertrophy reported on the electrocardiogram. β-Blocker and angiotensin-converting enzyme
inhibitor use was ascertained in the first visit following the diagnosis of HF. Hypertension and weight
were determined from the visit immediately before HF diagnosis. Glomerular filtration rate, smoking
status, marital status, systolic blood pressure, diastolic blood pressure, 15-ft walk time, left
ventricular hypertrophy reported by electrocardiogram, and height were ascertained from the
closest visit before or after the diagnosis of HF. Alcohol use assessment was ascertained at the first
visit after the diagnosis except among 22 participants who had missing data. In those cases, we used
the value immediately before the diagnosis was made, to which the mean difference in alcohol
consumption before and after the diagnosis derived from individuals with both values was added.
A 2-sided P < .05 defined statistical significance. Multiple linear regression has previously been
used in this data set to model associations between exposures and survival.19 Model assumptions
were evaluated by examining residual plots. After excluding former drinkers, we also assessed
alcohol use as a continuous variable, including a quadratic term to test for an inverted U-shaped
association between alcohol use and survival and adjustment for the same covariates. Mean
estimates of time from incident HF to death along with 95% CIs were subsequently derived from the
multivariable models. Sequential methods were used to impute missing baseline data.20 All analyses
were conducted using SAS, version 9.4 (SAS Institute Inc).
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Results
Of 393 individuals with incident HF, 213 (54.2%) were female, 339 (86.3%) were white, and the mean
(SD) age was 78.7 (6.0) years. In addition, 168 participants (42.7%) were abstainers from alcohol use,
96 (24.4%) were former drinkers, 112 (28.5%) were current drinkers consuming 7 or fewer drinks
per week, and 17 (4.3%) were current drinkers consuming more than 7 drinks per week (Table). All
but 22 of 393 individuals (5.6%) died during follow-up.
Across alcohol consumption categories of long-term abstainers, former drinkers, consumers of
1-7 drinks weekly and consumers of more than 7 drinks weekly, the percentage of men (54 of 168
[32.1%], 47 of 96 [49.0%], 65 of 112 [58.0%], and 14 of 17 [82.4%], respectively; P < .001 for trend),

Table. Patient Characteristics at Diagnosis of Heart Failure
Variable

Overall
(N = 393)

Long-term
Abstinence (n = 168)

Former Drinker
(n = 96)

≤7 Current
Drinks/wk (n = 112)

>7 Current
Drinks/wk (n = 17)

P Value (Differences
Among All Groups)

P Value
for Trenda

Age, mean (SD), y

78.7 (6.0)

78.4 (6.2)

78.8 (5.8)

79.2 (5.9)

77.1 (5.1)

.46

.32

Male, No. (%)

180 (45.8)

54 (32.1)

47 (49.0)

65 (58.0)

14 (82.4)

<.001

<.001

White

339 (86.3)

131 (78.0)

89 (92.7)

103 (92.0)

16 (94.1)

Black

51 (13.0)

36 (21.4)

6 (6.2)

8 (7.1)

1 (5.9)

.002

<.001b

Other

3 (0.8)

1 (0.6)

1 (1.0)

1 (0.9)

0

.48

.18c

<.001

<.001

<.001

<.001

Race/ethnicity, No. (%)

Marital status, No. (%)
Married

207 (52.7)

80 (47.6)

54 (56.2)

65 (58.0)

8 (47.1)

Widowed

162 (41.2)

76 (45.2)

35 (36.5)

42 (37.5)

9 (52.9)

Other

24 (6.1)

12 (7.1)

7 (7.3)

5 (4.5)

0

12 (10.0-14.0)

12 (8.0-12.0)

12 (11.0-14.0)

13 (12.0-15.0)

13 (12.0-14.0)

<16 000

156 (39.7)

90 (53.6)

34 (35.4)

30 (26.8)

2 (11.8)

16 000-24 999

94 (23.9)

41 (24.4)

20 (20.8)

29 (25.9)

4 (23.5)

≥25 000

143 (36.4)

37 (22.0)

42 (43.8)

53 (47.3)

11 (64.7)

Hypertension, No. (%)

274 (69.7)

122 (72.6)

64 (66.7)

76 (67.9)

12 (70.6)

.73

.45

Diabetes mellitus, No. (%)

105 (26.7)

54 (32.1)

25 (26.0)

25 (22.3)

1 (5.9)

.06

.01

History of myocardial
infarction, No. (%)

85 (21.6)

29 (17.3)

31 (32.3)

22 (19.6)

3 (17.6)

.04

.68

Educational level,
median (IQR), y
Income, No. (%), $

Atrial fibrillation, No. (%)

78 (19.8)

30 (17.9)

15 (15.6)

29 (25.9)

4 (23.5)

.23

.13

History of stroke, No. (%)

42 (10.7)

18 (10.7)

7 (7.3)

13 (11.6)

4 (23.5)

.23

.35

BMI, mean (SD)

27.6 (5.2)

28.2 (6.0)

27.7 (5.4)

26.8 (3.4)

26.0 (4.4)

.09

.14

.002

.006

Smoking status, No. (%)
Never

186 (47.3)

98 (58.3)

43 (44.8)

40 (35.7)

5 (29.4)

Former

160 (40.7)

58 (34.5)

37 (38.5)

56 (50.0)

9 (52.9)

Current

47 (12.0)

12 (7.1)

16 (16.7)

16 (14.3)

3 (17.6)

Systolic blood pressure,
mean (SD), mm Hg

137.6 (24.2)

137.2 (24.7)

138.6 (25.6)

138.4 (22.7)

131.4 (21.3)

.69

.86

Diastolic blood pressure,
mean (SD), mm Hg

67.4 (13.2)

67.1 (12.4)

69.0 (15.5)

66.3 (12.6)

68.0 (11.6)

.51

.75

Angiotensin-converting
enzyme inhibitor, No. (%)

167 (42.5)

65 (38.7)

46 (47.9)

50 (44.6)

6 (35.3)

.44

.51

β-Blocker, No. (%)

77 (19.6)

31 (18.5)

24 (25.0)

20 (17.9)

2 (11.8)

.47

.67

15-ft Walk time,
median (IQR), s

6 (5.0-8.0)

6 (5.0-9.0)

6 (5.0-7.0)

5 (4.0-7.0)

6 (4.0-9.0)

.001

<.001

GFR, mean (SD), ml/min

65 (20)

66 (20)

63 (21)

64 (18)

66 (20)

.76

.48

Left ventricular
hypertrophy by ECG,
No. (%)

63 (16.0)

32 (19.0)

11 (11.5)

19 (17.0)

1 (5.9)

.3

.31

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by
height in meters squared); ECG, electrocardiogram; GFR, glomerular filtration rate; IQR,
interquartile range.
a

<.001

b

White vs black or other.

c

Married vs widowed or other.

.03

Trend among long-term abstinence, 7 or fewer current drinks per week, and more than
7 current drinks per week.
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white individuals (131 [78.0%], 89 [92.7%], 103 [92.0%], and 16 [94.1%], respectively, P <. 001 for
trend), and high-income participants (37 [22.0%], 42 [43.8%], 53 [47.3%], and 11 [64.7%],
respectively; P < .001 for trend) increased with increasing alcohol consumption. Across the 4
categories, participants who consumed more alcohol had more years of education (mean, 12 years
[interquartile range (IQR), 8.0-10.0 years], 12 years [IQR, 11.0-14.0 years], 13 years [IQR, 12.0-15.0
years], and 13 years [IQR, 12.0-14.0 years]; P < .001 for trend). Diabetes was less common across the
alcohol consumption categories (54 [32.1%], 25 [26.0%], 25 [22.3%], and 1 [5.9%], respectively;
P = .01 for trend). Across alcohol consumption categories, there were fewer never smokers (98
[58.3%], 43 [44.8%], 40 [35.7%], and 5 [29.4%], respectively; P < .001 for trend) and more former
smokers (58 [34.5%], 37 [38.5%], 56 [50.0%], and 9 [52.9%], respectively; P = .006 for trend)
(Table). The mean 15-ft walk time was lowest (5 seconds [IQR, 4.0-7.0 seconds]), indicating better
fitness, in the moderate consumption group (ⱕ7 drinks/wk). The median survival after diagnosis of
HF was 7.5 years (IQR, 4.3-10.9 years). After controlling for other factors, consumption of 7 or fewer
drinks per week was associated with significantly longer survival following the diagnosis of HF
compared with abstinence (survival of an additional 383 days, 95% CI, 17-748 days; P = .04).
Although robustness was limited by the small number of individuals who consumed more than 7
drinks per week, a significant inverted U-shaped association between alcohol consumption and
survival was observed (Figure). Multivariable model estimates of mean time from heart failure
diagnosis and death were 2640 days (95% CI, 1967-3313 days) for never drinkers, 3046 days (95%
CI, 2372-3719 days) for consumers of 1 to 7 drinks per week, and 2806 days (95% CI, 1879-3734 days)
for consumers of more than 7 drinks per week (P = .02) (Figure). Consumption of 10 drinks per week
was associated with the longest survival, a mean of 3381 days (95% CI, 2806-3956 days) after heart
failure diagnosis.

Discussion
Among community-dwelling older adults, alcohol consumption of 7 or fewer drinks per week after
the diagnosis of HF was associated with longer survival compared with abstinence, after adjustment
for important covariates, including age, sex, race/ethnicity, educational level, income, smoking
status, marital status, hypertension, diabetes, stroke, myocardial infarction, atrial fibrillation,
angiotensin-converting enzyme inhibitor use, β-blocker use, systolic blood pressure, diastolic blood
pressure, body mass index, 15-ft walk time, glomerular filtration rate, and presence of left ventricular
hypertrophy reported on electrocardiography. Although mixed associations of alcohol use and
mortality have been observed in individuals with prevalent left ventricular dysfunction or HF,8-11 the
current study is unique to date because it analyzed survival in an inception cohort with HF and it
distinguished between former drinkers and abstainers.

Figure. Projected Survival After Diagnosis of Heart Failure by Weekly Alcohol Consumption
4500
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Our findings of increased survival among community-dwelling older adults with HF and
moderate alcohol consumption are consistent with observations reported in other studies in the
population of patients without HF.21-23 Moderate alcohol consumption appears to be protective
against coronary atherosclerotic events, perhaps because of increases in high-density lipoprotein
concentration, reductions in plasminogen activator, increases in plasminogen activator inhibitor
activities, and improvement in insulin sensitivity.24,25 Moreover, polyphenols found in beer and wine
increase nitric oxide concentration, which may have benefits in adults with HF.25
Current guidelines provide little guidance with respect to recommendations regarding alcohol
consumption in patients with HF: the 2010 Heart Failure Society of America guideline26 recommends
limiting alcohol consumption to no more than 2 drinks per day in men and 1 drink per day in women,
whereas the American College of Cardiology Foundation/American Heart Association and the
European Society of Cardiology guidelines27,28 are largely silent about the topic.
Our findings have potential implications for the 1 million adults aged more than 55 years who are
newly diagnosed with HF each year in the United States.12 In older patients with incident HF who
consumed alcohol before their diagnosis, limited alcohol consumption after the diagnosis appears to
be safe. Previous studies of patients with prevalent HF have found lower mortality8,9 and improved
perceived and objective health status10 with light to moderate alcohol consumption. By focusing on
individuals with newly diagnosed HF rather than prevalent HF, we reduced the likelihood that any
observed associations between alcohol consumption and survival were influenced by survivor bias.
Nevertheless, our findings should not be used to recommend that individuals who are newly
diagnosed with HF should initiate alcohol consumption if they had formerly been abstainers.
Likewise, patients with suspected alcohol-induced cardiomyopathy should continue to abstain from
alcohol consumption.

Limitations
Our study had several limitations. We used a single measure of alcohol consumption after the
diagnosis of HF and could not adjust for the association between subsequent changes in alcohol
consumption levels and survival. We did not have information about the cause of HF or about left
ventricular ejection fraction and cannot comment whether the associations of alcohol consumption
and survival differed among patients with reduced vs preserved left ventricular ejection fraction.
Given the limitations of our sample size, we did not perform subgroup analyses by age or sex. In
addition, the group of patients who consumed more than 7 drinks per week after the diagnosis of HF
consisted of only 17 individuals, limiting any conclusions that can be drawn about higher levels of
alcohol consumption. Despite attempts to control for important covariates, we cannot exclude the
possibility of residual confounding between alcohol use and other favorable prognostic factors
influencing its observed association with improved survival.

Conclusions
Alcohol use is common among older adults who have been diagnosed with HF. These findings
suggest that limited alcohol consumption among older adults with incident HF is associated with
survival benefit compared with long-term abstinence. Given the possibility of health benefits with
limited alcohol consumption following this diagnosis, further efforts to determine optimal levels of
alcohol consumption in adults with HF and whether this differs by age, sex, left ventricular ejection
fraction, or cause of HF are warranted.
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